Specify a stock or a cryptocurrency in the search bar to get a summary
Evofem Biosciences Inc
EVFMEvofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California. Address: 7770 Regents Roas, San Diego, CA, United States, 92122
Analytics
WallStreet Target Price
225 USDP/E ratio
0.0021Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures EVFM
Dividend Analytics EVFM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EVFM
Stock Valuation EVFM
Financials EVFM
Results | 2019 | Dynamics |